Wednesday, October 23, 2024
spot_img

Viomi Technology Co., Ltd Extends its Share Repurchase Plan

GUANGZHOU, China, Oct. 23, 2024 (GLOBE NEWSWIRE) — Viomi Technology Co., Ltd (“Viomi” or the “Company”) (NASDAQ: VIOT), a leading technology company for home water solutions in China, today announced that as part of the Company’s continuous commitment to enhancing shareholder value, its board of directors (the “Board”) has approved an extension of its existing share repurchase plan for an additional 12 months.

On October 25, 2022, the Board approved the share repurchase plan to repurchase up to US$10 million worth of the Company’s American Depositary Shares (ADSs) during the period from October 25, 2022, to October 24, 2024. On October 23, 2023, the Board extended this plan for twelve months.

Under this extended share repurchase plan, the Company may repurchase up to US$10 million worth of its ADSs between October 25, 2022, and October 24, 2025. To date, the Company has purchased an aggregate of US$901,258 worth of its ADSs in the open market.

The Company plans to continue funding the repurchases under the share repurchase plan using its existing cash balance.

About Viomi Technology

Viomi’s mission is “AI for Better Water,” utilizing AI technology to provide better drinking water solutions for households worldwide.

As an industry-leading technology company in home water solutions, Viomi has developed a distinctive “Equipment + Consumables” business model. By leveraging its expertise in AI technology, intelligent hardware and software development, the Company simplifies filter replacement and enhances water quality monitoring, thereby increasing the filter replacement rate. Its continuous technological innovations extend filter lifespan and lower user costs, promoting the adoption of water purifiers and supporting a healthy lifestyle while effectively addressing the rising global demand for cleaner, fresher and healthier drinking water. The Company operates a world-leading “Water Purifier Gigafactory” with an integrated industrial chain that boasts optimal efficiency and facilitates continuous breakthroughs in water purification. This state-of-the-art facility enables Viomi to achieve economies of scale and accelerate the global popularization of residential water filtration.

For more information, please visit: https://ir.viomi.com.

Safe Harbor Statement

This announcement contains forward-looking statements. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates,” “confident” and similar statements. Among other things, the business outlook and quotations from management in this announcement, as well as Viomi’s strategic and operational plans, contain forward-looking statements. Viomi may also make written or oral forward-looking statements in its periodic reports to the United States Securities and Exchange Commission (the “SEC”), in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Statements that are not historical facts, including statements about the Company’s beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: the Company’s growth strategies; the cooperation with Xiaomi, the recognition of the Company’s brand; trends and competition in global IoT-enabled smart home market; development and commercialization of new products, services and technologies; governmental policies and relevant regulatory environment relating to the Company’s industry and/or aspects of the business operations and general economic conditions in China and around the globe, and assumptions underlying or related to any of the foregoing. Further information regarding these and other risks is included in the Company’s filings with the SEC. All information provided in this press release is as of the date of this press release, and the Company undertakes no obligation to update any forward-looking statement, except as required under applicable law.

For investor and media inquiries, please contact:

In China:

Viomi Technology Co., Ltd
Claire Ji
E-mail: [email protected]

Piacente Financial Communications
Hui Fan
Tel: +86-10-6508-0677
E-mail: [email protected]  

In the United States:

Piacente Financial Communications
Brandi Piacente
Tel: +1-212-481-2050
E-mail: [email protected]  

Powered by SlickText.com

Hot this week

Alliance Witan PLC – Transaction In Own Shares

Alliance Witan PLCLEI: 213800SZZD4E2IOZ9W55  TRANSACTION IN OWN SHARES  Alliance Witan...

Weekly share repurchase program transaction details

October 23, 2024 SBM Offshore reports the transaction...

PayPoint plc : Director/PDMR Shareholding

23 October 2024 PayPoint plc ("the Company") ...

Transaction in Own Shares

Transaction in Own Shares 23 October, 2024 ...

Umicore – Transparency notifications by BlackRock, Inc. and by Bank of America Corp.

Transparency notifications by BlackRock, Inc. and by Bank of...

Topics

Alliance Witan PLC – Transaction In Own Shares

Alliance Witan PLCLEI: 213800SZZD4E2IOZ9W55  TRANSACTION IN OWN SHARES  Alliance Witan...

Weekly share repurchase program transaction details

October 23, 2024 SBM Offshore reports the transaction...

PayPoint plc : Director/PDMR Shareholding

23 October 2024 PayPoint plc ("the Company") ...

Transaction in Own Shares

Transaction in Own Shares 23 October, 2024 ...

Umicore – Transparency notifications by BlackRock, Inc. and by Bank of America Corp.

Transparency notifications by BlackRock, Inc. and by Bank of...

Daré Bioscience Selected to Receive $10 Million Award from ARPA-H’s Sprint for Women’s Health

DARE-HPV is a potential first-in-category treatment for human papillomavirus...

SYNERGIE : Q3 2024 REVENUES

Q3 2024 REVENUES In challenging market conditions, SYNERGIE...

2024 third quarter turnover: 131.1 million euros

2024 third quarter turnover: 131.1 million euros ...
spot_img

Related Articles

Popular Categories

spot_img